Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine.

Keller, D

Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine. [electronic resource] - JAMA Jun 1994 - 1764-8 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0098-7484


Adolescent
Adult
Antibody Formation
Antigens, Surface--immunology
Bacterial Outer Membrane Proteins--immunology
Bacterial Vaccines
Borrelia burgdorferi Group--immunology
Double-Blind Method
Female
Humans
Immunization Schedule
Immunoglobulin G--immunology
Immunologic Tests
Lipoproteins
Lyme Disease--prevention & control
Male
Microbial Sensitivity Tests
Middle Aged